https://www.selleckchem.com/pr....oducts/mizagliflozin
All rights reserved. This article is protected by copyright. All rights reserved.OBJECTIVES To identify predictors of poor overall survival (OS) among penile squamous-cell carcinoma (pSCC) patients with clinical inguinal lymphadenopathy (cN+) in order to define the best candidate for neoadjuvant chemotherapy (NAC). MATERIALS AND METHODS Using an international, multicenter database of 924 pSCC patients, we identified 334 cN+ men with available clinical and follow-up data. Lymph node involvement was defined either by the presence of
Like
Comment
Share
